BioCentury | Apr 9, 2014
Financial News

AdvanDx secures $12 million in B-1 round

Molecular diagnostics company AdvanDx Inc. (Woburn, Mass.) raised $9 million in a $12 million series B-1 round led by new investor Merck Global Health Innovation Fund. Existing investors SLS Ventures and LD Pensions also participated....
BioCentury | Aug 24, 2009
Financial News

AdvanDx financial update

...series C round, bringing the total raised in the round to $23 million. Existing investors SLS Venture...
BioCentury | Jun 29, 2009
Financial News

Gyros completes venture financing

...Sweden Business: Microfluidics Date completed: 6/29/09 Type: Venture financing Raised: SEK80 million ($10.1 million) Investors: SLS Venture...
BioCentury | Jan 18, 2008
Financial News

Action Pharma raises EUR 15 million

...$22.2 million) in a series D round led by Global Life Science Ventures. New investor SLS Venture...
Items per page:
1 - 4 of 4
BioCentury | Apr 9, 2014
Financial News

AdvanDx secures $12 million in B-1 round

Molecular diagnostics company AdvanDx Inc. (Woburn, Mass.) raised $9 million in a $12 million series B-1 round led by new investor Merck Global Health Innovation Fund. Existing investors SLS Ventures and LD Pensions also participated....
BioCentury | Aug 24, 2009
Financial News

AdvanDx financial update

...series C round, bringing the total raised in the round to $23 million. Existing investors SLS Venture...
BioCentury | Jun 29, 2009
Financial News

Gyros completes venture financing

...Sweden Business: Microfluidics Date completed: 6/29/09 Type: Venture financing Raised: SEK80 million ($10.1 million) Investors: SLS Venture...
BioCentury | Jan 18, 2008
Financial News

Action Pharma raises EUR 15 million

...$22.2 million) in a series D round led by Global Life Science Ventures. New investor SLS Venture...
Items per page:
1 - 4 of 4